Table 1.
Main clinical features in MetS and control subjects.
| Variable | Controls (n = 147) | MetS (n = 215) | P |
|---|---|---|---|
| Age (yr) | 53.8 ± 9.2 | 54.6 ± 8.2 | 0.124 |
| Sex (femal %) | 59.9% (88, 59) | 54.4% (117, 98) | 0.332 |
| BMI (kg/m2) | 22.9 ± 3.0 | 25.4 ± 2.6 | <0.001 |
| FAT (%) | 26.3 ± 5.9 | 31.3 ± 7.0 | <0.001 |
| WHR | 0.87 ± 0.08 | 0.93 ± 0.06 | <0.001 |
| SBP (mmHg) | 116.8 ± 15.0 | 131.8 ± 18.6 | <0.001 |
| DBP (mmHg) | 73.5 ± 9.6 | 82.6 ± 12.1 | <0.001 |
| TC (mmol/L) | 4.59 ± 1.03 | 4.90 ± 1.35 | 0.021 |
| TG (mmol/L) | 1.15 (0.80–1.50) | 2.00 (1.40–2.70) | <0.001 |
| HDL-C (mmol/L) | 1.40 ± 0.60 | 1.10 ± 0.25 | <0.001 |
| LDL-C (mmol/L) | 2.67 ± 0.76 | 2.90 ± 0.98 | 0.015 |
| FFA (µmol/L) | 0.51 (0.38–0.65) | 0.64 (0.44–0.90) | <0.001 |
| HBA1c (%) | 5.6 ± 0.4 | 7.1 ± 1.9 | <0.001 |
| FBG (mmol/L) | 5.2 ± 0.6 | 7.8 ± 4.0 | <0.001 |
| 2h-BG (mmol/L) | 6.3 ± 1.2 | 13.2 ± 8.2 | <0.001 |
| FIns (mU/L) | 8.6 (5.6–13.0)(143) | 15.8 (9.5–22.7)(174) | <0.001 |
| HOMA-IR | 1.97 (1.30–3.02)(143) | 5.04 (3.66–6.75)(174) | <0.001 |
BMI, Body mass index; FAT (%), the percentage of fat in vivo; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; TG, Triglyceride; TC, Total cholesterol; HDL-C, High- density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; FFA, free fatty acid; HbA1c, Glycosylated hemoglobin; FBG, Fasting blood glucose; 2h-BG, 2 h post-glucose load blood glucose; FIns, Fasting plasma insulin; HOMA-IR, HOMA-insulin resistance index. Values are means ± SD or median (interquartile Range).